A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/16 (2006.01) A61K 9/26 (2006.01) A61K 9/36 (2006.01) A61K 9/48 (2006.01) A61K 31/4535 (2006.01)
Patent
CA 2696984
The present invention relates to a pharmaceutical formulation of solid dosage forms comprising a therapeutically effective amount of a selective estrogen receptor modulator, and especially Raloxifene or a pharmaceutical acceptable salt thereof, in combination with a super disintegrant such as Primojel, and a process for the preparation thereof by wet granulation.
La présente invention concerne une formulation pharmaceutique de formes de dosage solide comprenant une quantité thérapeutiquement efficace d'un modulateur de récepteur strogène sélectif, et en particulier le Raloxifène ou un sel pharmaceutique acceptable de celui-ci, en combinaison avec un super-désintégrant tel que le Primojel. La présente invention concerne également un procédé de préparation de celui-ci par granulation humide.
Bikiaris Dimitrios
Kalaskani Anastasia
Karavas Evangelos
Koutris Efthimios
Samara Vicky
Dimock Stratton Llp
Pharmathen S.a.
LandOfFree
Improved pharmaceutical composition containing a selective... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Improved pharmaceutical composition containing a selective..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved pharmaceutical composition containing a selective... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1382139